Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Delcath Systems, Inc. is a US-based company specialising in innovative medical technologies within the precision and optical instruments sector, including watches and clocks. Headquartered in the United States, the company operates across multiple regions, focusing on developing advanced treatments for cancer patients. Founded in 1988, Delcath has established a strong reputation for its proprietary drug delivery systems, notably its Hepatic Delivery System, which offers targeted therapy for liver cancers.
The company's core offerings centre on its unique approach to delivering high-dose chemotherapy directly to tumours while minimising systemic exposure. This innovative method has positioned Delcath as a leader in the field of interventional oncology. With notable milestones in clinical development and regulatory approvals, Delcath continues to advance its market position as a pioneer in precision medical solutions.
18
DitchCarbon score
-14 vs industry average
Delcath Systems, Inc.’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Delcath Systems, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Low
Medical Device Manufacturing has below-average carbon intensity
Industry performance
0.308
20182025
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for Delcath Systems, Inc. yet.
Delcath Systems, Inc.'s reported carbon emissions
Delcath Systems, Inc., headquartered in the US and operating within the Medical, precision and optical instruments, watches and clocks industry (33), has not publicly disclosed specific carbon emissions data for recent years. Therefore, information regarding their absolute emissions in kg CO2e, including Scope 1, Scope 2, and Scope 3, is not available.
Consequently, details on their reduction targets, such as Science Based Targets initiative (SBTi) commitments or participation in initiatives like the Climate Pledge, are also not publicly documented at this time. As a company in the medical instruments sector, Delcath Systems may be subject to evolving environmental regulations and industry best practices concerning greenhouse gas emissions and climate impact. Further disclosures on their climate strategy and performance are anticipated.
Assessing Delcath Systems, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Delcath Systems, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Delcath Systems, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Delcath Systems, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Delcath Systems, Inc.1 year ago
18
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more